Candidemia in neonatal intensive care units: Barcelona, Spain

Pediatric Infectious Disease Journal

Volumn 25, Issue 3, 2006, Pages 224-229

  Rodriguez, Dolors ^a   Almirante, Benito ^a   Park, Benjamin J ^b   Cuenca Estrella, Manuel ^c   Planes, Ana M ^a   Sanchez, Ferran ^d   Gene, Amadeu ^e   Xercavins, Mariona ^f   Fontanals, Dionisia ^g   Rodriguez Tudela, Juan L ^c   Warnock, David W ^b   Pahissa, Albert ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL SANT JOAN DE DÉU   (Spain)

^f HOSPITAL MÚTUA DE TERRASSA   (Spain)

^g HOSPITAL DE SABADELL   (Spain)

Author keywords

Azole resistance; Candidemia; Epidemiology; Neonatal intensive care unit; Risk factors for candidemia

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; PYRROLE DERIVATIVE;

ARTICLE; CANDIDA; CANDIDA PARAPSILOSIS; CANDIDEMIA; CLINICAL ARTICLE; DRUG SENSITIVITY; ENDOCARDITIS; ENDOPHTHALMITIS; FEMALE; FUNGEMIA; FUNGUS ISOLATION; GESTATIONAL AGE; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT MORTALITY; MALE; MENINGITIS; MORBIDITY; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; PERITONITIS; PREMATURITY; PRIORITY JOURNAL; SPAIN; VERY LOW BIRTH WEIGHT;

CANDIDA; CANDIDIASIS; FUNGEMIA; HUMANS; INCIDENCE; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; POPULATION SURVEILLANCE; RISK FACTORS; SPAIN;

EID: 33644911531     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000202127.43695.06     Document Type: Article

References (44)

1. Beck-Sague CM, Jarvis WR and the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis. 1993; 167:1247-1251.
2. Jarvis WR. Epidemiology of nosocomial fungal infections with emphasis on Candida species. Clin Infect Dis. 1995;20:1526-1530.
3. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in NICU patients. Pediatr Infect Dis J. 2000;19:319-324.
4. Faix RG, Kovaarik SM, Shaw TR, Johson RV. Mucocutaneous and invasive candidiasis among very low birth weight (1,500 gr) infants in intensive care nurseries: a prospective study. Pediatrics. 1989;83:101-107.
5. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998;17:504-508.
6. Saxen H, Virtanen M, Carlson P, et al. Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J. 1995;14:776-781.
7. Saiman L, Ludington E, Dawson J, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20:1119-1124.
8. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics. 1984;73:144-152.
9. Faix RG. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J. 1992;11:88-93.
10. Levy I, Rubin LG, Vasishtha S, et al. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis. 1998;26:1086-1088.
11. Pacheco-Rios A, Avila-Figueroa C, Nobigrot-Kleinman D, Santos JI. Mortality associated with systemic candidiasis in children. Arch Med Res. 1997;28:229-232.
12. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis. 1995;20:571-575.
13. Nucci M, Colombo AL, Silveira S, et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol. 1998;19:846-850.
14. Weems JJ Jr. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin infect Dis. 1992;14:756-766.
15. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very-low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285-291.
16. Lopez-Sastre JB, Gil D, Coto-Coballo MD, Fernandez B and Grupo de Hospitales Castrillo. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol. 2003;20:153-163.
17. Leibovitz E, Iuster-Reicher A, Amitai M, Mogilner B. Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis. 1992;14:485-491.
18. Webel SF, McNeil MM, Kuykendall RJ, et al. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of common source outbreak. Pediatr Infect Dis J. 1996;15:998-1002.
19. Chowdhary A, Becker K, Fegeler W, et al. An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit. Mycoses. 2003;46:269-274.
20. Almirante B, Rodríguez D, Park BJ, et al. Epidemiology and predictors of mortality in Candida bloodstream infections: results from population-based surveillance, Barcelona, Spain, 2002-2003. J Clin Microbiol. 2005;43:1829-1835.
21. Raad I, Hanna H, Boktour M, et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004;38:1119-1127.
22. Rodriguez-Tudela JL, Barchiesi F, Bille J, et al. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect. 2003;9:I-VIII.
23. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing or Yeast: Approved Standard. 2nd ed. Document M27-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2002.
24. Benjamin DK Jr, Ross K, McKinney RE Jr, Benjamin DK, Auten R, Fisher RG. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteria. Pediatrics. 2000;106:712-718.
25. Baley JE, Silverman RA. Systemic candidiasis: cutaneous manifestations in low birth weight infants. Pediatrics. 1988;82:211-215.
26. Faix RG. Systemic Candida infections in infant in intensive care nurseries: high incidence of central venous system involvement. J Pediatr. 1984;105:616-622.
27. Huttova M, Hartmanova I, Kralinsky K, et al. Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. Pediatr Infect Dis J. 1998;17:1012-1015.
28. Juster-Reicher A, Flidel-Rimon O, Amitay M, et al. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates. Eur J Clin Microbiol Infect Dis. 2003;22:603-607.
29. Cuenca-Estrella M, Rodríguez D, Almirante B, et al. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J Antimicrob Chemother. 2005;55:194-199.
30. Fairchild KD, Tomkoria S, Sharp E, Mena F. Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediat Infect Dis J. 2002;21:39-43.
31. Lee BE, Cheung PY, Robinson JL, et al. Comparative study of mortality and morbidity in prematures infants (birth weight <1250 g) with candidemia or candidal meningitis. Clin Infect Dis. 1998;27:559-565.
32. Johnson DE, Thompson TR, Green TP, Ferrieri P. Systemic candidiasis in very low-birth-weight infants (<1,500 grams). Pediatrics. 1984;73:138-143.
33. Weese-Mayer DE, Fondriest DW, Brouillette RT, Shulman ST. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J. 1987;6:190-196.
34. El-Masry F, Neal TJ, Subhedar NV. Risk factors for invasive fungal infection in neonates. Acta Paediatr. 2002;91:198-202.
35. Makhoul IR, Sujov P, Smolkin T, et al. Epidemiological, clinical and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a nation survey. Pediatrics. 2002;109:34-39.
36. Makhoul IR, Kassis I, Smolkin T, et al. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics. 2001;107:61-66.
37. Warris A, Semmekrot A, Voss A. Candidal and bacterial bloodstream infections in premature neonates: a case control study. Med Mycol. 2001;39:75-79.
38. Benjamin DK, Garges H, Steinbach WJ. Candida bloodstream infections in neonates. Semin Perinatol. 2003;27:375-383.
39. Levin AS, Costa SF, Mussi NS, et al. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis. 1998;30:243-249.
40. Kaufman D. Fungal infection in the very low birth weight infant. Curr Opin Infect Dis. 2004;17:253-259.
41. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345:1660-1666.
42. Benjamin DK, DeLong E, Steinbach WJ, et al. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics. 2003;112:543-547.
43. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B, in collaboration with the Israel Neonatal Network. Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey. Clin Infect Dis. 2005;40:218-224.
44. Rodriguez D, Almirante B, Cuenca-Estrella M, et al. Candidemia in neonatal intensive care unit (NICU) patients. In: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 30-November 2, 2004, Washington, DC. Washington, DC: American Society for Microbiology; 2004. Abstract M-1045.